Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080871 · ClinicalTrials.gov registry record · NA
A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT02080871: Completed NA study, sponsored by W.L.Gore & Associates.
NCT02080871 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02080871, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Evaluation of the Gore(R) VIABAHN BX for the treatment of arterial occlusive disease in the common and/or external iliac arteries.
Primary Outcome
Percentage of study subjects experiencing a major adverse event (MAE) defined as: device or procedure-related death within 30 days, myocardial infarction (MI) within 30 days, target lesion revascularization (TLR) within 9 months or major amputation of the target limb within 9 months.
Interventions
- DEVICE Stenting of the Common and/or External Iliac Arteries
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02080871 record still lists
NCT02080871 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Stenting of the Common and/or External Iliac Arteries is the first listed.
NCT02080871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02080871 about?
NCT02080871 is a clinical study titled "A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.". Evaluation of the Gore(R) VIABAHN BX for the treatment of arterial occlusive disease in the common and/or external iliac arteries.
What is the current status of trial NCT02080871?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2014-07. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02080871?
The interventions under investigation include: Stenting of the Common and/or External Iliac Arteries (DEVICE).
Who is sponsoring clinical trial NCT02080871?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02080871's enrollment target sits among peer trials
134 728th of 2000 higher than 1,272 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia